Health technology assessment in Canada.

Providing Value to New Health Technology: The Early Contribution of Entrepreneurs, Investors, and Regulatory Agencies

Background New technologies constitute an important cost-driver in healthcare, but the dynamics that lead to their emergence remains poorly understood from a health policy standpoint. The goal of this paper is to clarify how entrepreneurs, investors, and regulatory agencies influence the value of emerging health technologies.   Methods Our 5-year qualitative research program examined the proces...

Why Learning How to Chase Butterflies Matters: A Response to Recent Commentaries

Public Spending on Health Service and Policy Research in Canada, the United Kingdom, and the United States: A Modest Proposal

Health services and policy research (HSPR) represent a multidisciplinary field which integrates knowledge from health economics, health policy, health technology assessment, epidemiology, political science among other fields, to evaluate decisions in health service delivery. Health service decisions are informed by evidence at the clinical, organizational, and policy level, levels with distinct...

Disease Control Priorities Third Edition: Time to Put a Theory of Change Into Practice; Comment on “Disease Control Priorities Third Edition Is Published: A Theory of Change Is Needed for Translating Evidence to Health Policy”

The Disease Control Priorities program (DCP) has pioneered the use of economic evidence in health. The theory of change (ToC) put forward by Norheim is a further welcome and necessary step towards translating DCP evidence into better priority setting in low- and middle-income countries (LMICs). We also agree that institutionalising evidence for informed priority-setting processes is crucial. Un...

Genetic considerations for a woman's pre-conception evaluation.

OBJECTIVE To give health care providers information about the genetic information that can be used as part of health surveillance for women undergoing a pre-conception evaluation for genetic risk assessment and possible genetic screening or testing. OPTIONS This genetic information can be used for patient education and possible prenatal testing. OUTCOMES The use of this genetic information ...